title: Comparing dopamine D(2) receptor occupancies for use in clinical practice: attractive proposition but fraught with pitfalls.
authors.affiliation: Research Division Department of General Psychiatry 1 & Research Division Institute of Mental Health Buangkok View, Singapore and Duke-NUS Graduate Medical School College Road, Singapore and Schizophrenia Division Centre for Addiction and Mental Health Toronto, Ontario, Canada and Department of Psychiatry University of Toronto Toronto, Ontario, Canada jimmy_lee@imh.com.sg Schizophrenia Division Centre for Addiction and Mental Health Toronto, Ontario, Canada and Department of Psychiatry University of Toronto Toronto, Ontario, Canada and Department of Neuropsychiatry School of Medicine Keio University Tokyo, Japan Schizophrenia Division Centre for Addiction and Mental Health Toronto, Ontario, Canada and Department of Psychiatry University of Toronto Toronto, Ontario, Canada.
authors.forename: Jimmy
authors.initials: J
authors.lastname: Lee
authors.forename: Hiroyoshi
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Gary
authors.initials: G
authors.lastname: Remington
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001921:Brain / Q000187:drug effects*; D018492:Dopamine Antagonists / Q000008:administration & dosage*; D065127:Dopamine D2 Receptor Antagonists; D005260:Female; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists